In Vivo CAR-T Therapy in 2026: Are We About to Change How Cell Therapy Is Made?
by What if CAR-T therapy no longer required collecting a patient’s immune cells, sending them to a specialized manufacturing facility, genetically engineering them, expanding them, testing …